10 Jan
Asymptomatic primary hyperparathyroidism: Conservative management of asymptomatic hyperparathyroidism part 3
Calcimimetics. A more targeted approach to the medical therapy of primary hyperparathyroidism is to interfere specifically with the production of PTH. A new class of agents that alters the function of the extracellular calcium-sensing receptor offers an exciting new approach to primary hyperparathyroidism. By binding to an allosteric site, these agents increase the affinity of [...]